Outcomes of Intravesical Botulinum Toxin for Idiopathic Overactive Bladder Symptoms: A Systematic Review of the Literature

Journal of Urology

Volumn 183, Issue 6, 2010, Pages 2258-2264

  Anger, Jennifer T ^a   Weinberg, Aviva ^a   Suttorp, Marika J ^b   Litwin, Mark S ^a   Shekelle, Paul G ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RAND CORPORATION   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

overactive; treatment outcome; urge; urinary bladder; urinary incontinence

Indexed keywords

BOTULINUM TOXIN A; CHOLINERGIC RECEPTOR BLOCKING AGENT; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DYSURIA; GENETIC HETEROGENEITY; HEMATURIA; HUMAN; OUTCOME ASSESSMENT; OVERACTIVE BLADDER; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; URINARY TRACT INFECTION; URINE RETENTION;

ADMINISTRATION, INTRAVESICAL; BOTULINUM TOXIN TYPE A; HUMANS; NEUROMUSCULAR AGENTS; TREATMENT OUTCOME; URINARY BLADDER, OVERACTIVE;

EID: 77951880569     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.02.009     Document Type: Article

References (18)

1. Sahai A., Khan M.S., and Dasgupta P. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial. J Urol 177 (2007) 2231
2. Giannantoni A., Di Stasi S.M., Stephen R.L., et al. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study. J Urol 172 (2004) 240
3. Schurch B., Stohrer M., Kramer G., et al. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164 (2000) 692
4. Duthie J., Wilson D.I., Herbison G.P., et al. Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev (2007) CD005493
5. Flynn M.K., Amundsen C.L., Perevich M., et al. Outcome of a randomized, double-blind, placebo controlled trial of botulinum A toxin for refractory overactive bladder. J Urol 181 (2009) 2608
6. Brubaker L., Richter H.E., Visco A., et al. Refractory idiopathic urge urinary incontinence and botulinum A injection. J Urol 180 (2008) 217
7. Shea B.J., Grimshaw J.M., Wells G.A., et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 15 (2007) 7
8. Anger J.T. www.uclahealth.org/jenniferanger
9. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1
10. Furukawa T., Barbui C., Cipriani A., et al. Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol 59 (2006) 7
11. Yusuf S., Peto R., Lewis J., et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 27 (1985) 335
12. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177
13. Higgins J., Thompson S., Deeks J., et al. Measuring inconsistency in meta-analysis. BMJ 327 (2003) 557
14. Begg C.B., and Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (1994) 1088
15. Egger M., Davey Smith G., Schneider M., et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629
16. Brubaker L., Kreder K., Richter H.E., et al. Refractory urge urinary incontinence and botulinum a injection: the methods of the RUBI trial. J Appl Res 6 (2006) 260
17. Guyatt G.H., Osoba D., Wu A.W., et al. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 77 (2002) 371
18. Apostolidis A., Dasgupta P., Denys P., et al. Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. Eur Urol 55 (2009) 100